BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27683114)

  • 1. Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
    Rieke DT; Ochsenreither S; Klinghammer K; Seiwert TY; Klauschen F; Tinhofer I; Keilholz U
    Oncotarget; 2016 Nov; 7(46):75379-75393. PubMed ID: 27683114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.
    Starzer AM; Heller G; Tomasich E; Melchardt T; Feldmann K; Hatziioannou T; Traint S; Minichsdorfer C; Schwarz-Nemec U; Nackenhorst M; Müllauer L; Preusser M; Berghoff AS; Fuereder T
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The landscape of
    de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
    Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
    Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
    J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer.
    Feng B; Shen Y; Pastor Hostench X; Bieg M; Plath M; Ishaque N; Eils R; Freier K; Weichert W; Zaoui K; Hess J
    Clin Cancer Res; 2020 Jul; 26(14):3616-3628. PubMed ID: 32161122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.
    Bates AM; Lanzel EA; Qian F; Abbasi T; Vali S; Brogden KA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Aug; 124(2):157-164. PubMed ID: 28756882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation biomarkers for head and neck squamous cell carcinoma.
    Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
    Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
    de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
    J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
    Hoffmann F; Franzen A; de Vos L; Wuest L; Kulcsár Z; Fietz S; Maas AP; Hollick S; Diop MY; Gabrielpillai J; Vogt T; Kuster P; Zarbl R; Dietrich J; Kristiansen G; Brossart P; Landsberg J; Strieth S; Dietrich D
    Clin Epigenetics; 2023 Jul; 15(1):112. PubMed ID: 37415208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
    Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
    Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
    Chae YK; Anker JF; Oh MS; Bais P; Namburi S; Agte S; Giles FJ; Chuang JH
    Sci Rep; 2019 Mar; 9(1):3235. PubMed ID: 30824826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-inhibitory immune checkpoints in head and neck squamous cell carcinoma.
    Deng WW; Wu L; Sun ZJ
    Oral Dis; 2018 Mar; 24(1-2):120-123. PubMed ID: 29480599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
    Franzen A; Bootz F; Dietrich D
    HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
    Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
    DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
    Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
    J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
    Li X; Cai Y
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
    Solomon B; Young RJ; Rischin D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA methylation landscape of
    Bockhorst C; Dietrich J; Vogt TJ; Stauber RH; Strieth S; Bootz F; Dietrich D; Vos L
    Epigenomics; 2021 Jan; 13(2):113-127. PubMed ID: 33351665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.